Matthews Judith M.

CIK 00017340331 companyDUBLIN, L2

SEC Profile

Transactions

Companies

Filings

CIK

0001734033

Recent Transactions

22 trades

Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2023-03-31+100,000→ 100,000 total
Award
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-03-11+6,666→ 11,018 total
Tax Payment
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-03-11$0.96/sh−2,883→ 8,135 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-03-11−6,666→ 0 total
Sale
Iterum Therapeutics plc$ITRM
Ordinary Shares
2022-03-14$0.31/sh−63,340→ 65,292 total
Sale
Iterum Therapeutics plc$ITRM
Ordinary Shares
2022-03-14$0.38/sh−47,132→ 81,500 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-03-11−100,000→ 100,000 total
Award
Iterum Therapeutics plc$ITRM
Ordinary Shares
2022-03-11+100,000→ 128,632 total
Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2021-06-23+1,936,000→ 1,936,000 total
Award
Iterum Therapeutics plc$ITRM
Restricted Share Units
2021-03-11+200,000→ 200,000 total
Sale
Iterum Therapeutics plc$ITRM
Ordinary Shares
2021-01-26$1.73/sh−33,868→ 28,632 total
Award
Iterum Therapeutics plc$ITRM
Ordinary Shares
2021-01-25+62,500→ 62,500 total
Sale
Iterum Therapeutics plc$ITRM
Ordinary Shares
2020-09-30$1.64/sh−56,130→ 0 total
Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2019-02-15+30,000→ 30,000 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-2 Preferred Shares
2018-05-30−2,466→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+10,980→ 46,626 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+2,466→ 52,130 total
Conversion
Iterum Therapeutics plc$ITRM
Series A Preferred Shares
2018-05-30−10,980→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+3,038→ 49,664 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30$13.00/sh+4,000→ 56,130 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-1 Preferred Shares
2018-05-30−3,038→ 0 total
Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2018-05-24+23,870→ 23,870 total

Companies

Iterum Therapeutics plc
Chief Financial Officer
$ITRM

Recent Filings

Address

C/O ITERUM THERAPEUTICS PLC, BLK 2 FL. 3, HARCOURT CENTRE, HARCOURT ST.

DUBLIN, L2, 2

View on SEC.gov